National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8 Study in ALS

05.10.2023 - Funding to Support Research and Expanded Access of Investigational Drug in ALSSALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) - Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia ... Seite 1

Related Keywords

Benjamin Greenberg ,Jinsya Andrews ,Eric Anderson ,Clene Inc ,Nasdaq ,National Institute Of Neurological Disorders ,Division Of Neuromuscular Medicine ,National Institutes Of Health ,Funding To Support Research ,Columbia University ,Drug Administration ,Clene Nanomedicine Inc ,Support Research ,Expanded Access ,Investigational Drug ,Clene Nanomedicine ,National Institute ,Neurological Disorders ,National Institutes ,Expanded Access Protocol ,Compassionate Use ,Accelerating Access ,Critical Therapies ,President Biden ,Neuromuscular Medicine ,Neuromuscular Clinical Trials ,Columbia University Vagelos College ,Clene Chart ,Lene Kurs ,Lene Aktie ,